Saphenous vein: advances
- 63 Downloads
Although the saphenous vein (SV) is a widely used conduit for coronary artery bypass graft surgery (CABG), lower long-term graft patency rates and worse clinical outcomes have been reported after CABG performed with SV grafts compared with CABG performed with internal thoracic artery (ITA) grafts. Of various efforts to overcome the limitations of SV that are resulting from structural and functional differences from arterial conduit, recent improvement in harvesting techniques including no-touch technique, surgical strategy of using the SV as part of a composite graft over an aortocoronary bypass graft, and external stenting of the SV will be discussed in this topic.
KeywordsCoronary artery bypass graft surgery Saphenous vein Composite graft
Compliance with ethical standards
Conflict of interest
Prof. David Taggart states that he has received research funding, speaking, and traveling honoraria from Vascular Graft Solutions (VGS), and also has share options in VGS.
Ki-Bong Kim, Ho Young Hwang, and Domingos Souza state that they have no conflict of interest.
Human and animal rights and informed consent
This article does not contain any studies with human participants or animals performed by any of the authors.
- 3.Campeau L, Enjalbert M, Lespérance J, Vaislic C, Grondin CM, Bourassa MG. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. Circulation. 1983;68:II1–7.Google Scholar
- 7.Ratliff NB, Myles JL. Rapidly progressive atherosclerosis in aortocoronary saphenous vein grafts. Possible immune-mediated disease. Arch Pathol Lab Med. 1989;113:772–6.Google Scholar
- 9.Wan S, Shukla N, Angelini GD, Yim AP, Johnson JL, Jeremy JY. Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1). J Thorac Cardiovasc Surg. 2007;134:1033–9.CrossRefGoogle Scholar
- 16.Dashwood MR, Savage K, Tsui JC, et al. Retaining perivascular tissue of human saphenous vein grafts protects against surgical and distension-induced damage and preserves endothelial nitric oxide synthase and nitric oxide synthase activity. J Thorac Cardiovasc Surg. 2009;138:334–40.CrossRefGoogle Scholar
- 17.Johansson BL, Souza DS, Bodin L, et al. Slower progression of atherosclerosis in vein grafts harvested with “no touch” technique compared with conventional harvesting technique in coronary artery bypass grafting: an angiographic and intravascular ultrasound study. Eur J Cardiothorac Surg. 2010;38:414–9.CrossRefGoogle Scholar
- 18.Johansson B, Samano N, Souza D, et al. The no-touch vein graft for coronary artery bypass surgery preserves the left ventricular ejection fraction at 16 year postoperatively: long-term data from a longitudinal randomised trial. Open Heart. 2015;2:e000204. https://doi.org/10.1136/openhrt-2014-000204.CrossRefGoogle Scholar
- 34.Rescigno G, Aratari C, Matteucci SM, et al. Saphenous vein graft wrapping by nitinol mesh: A word of caution. Thorac Cardiovasc Surg. 2015;63:292–7.Google Scholar